Brawn Biotech Limited (BOM:530207)

Brawn Biotech Statistics

Total Valuation

Brawn Biotech has a market cap or net worth of INR 66.01 million. The enterprise value is 64.11 million.

Market Cap	66.01M
Enterprise Value	64.11M

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Brawn Biotech has 3.00 million shares outstanding. The number of shares has decreased by -9.75% in one year.

Current Share Class	3.00M
Shares Outstanding	3.00M
Shares Change (YoY)	-9.75%
Shares Change (QoQ)	+7.71%
Owned by Insiders (%)	54.83%
Owned by Institutions (%)	n/a
Float	953,024

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.39
PB Ratio	1.78
P/TBV Ratio	1.78
P/FCF Ratio	n/a
P/OCF Ratio	197.46
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.43
EV / Sales	0.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-54.57

Financial Position

The company has a current ratio of 1.15

Current Ratio	1.15
Quick Ratio	0.39
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-231.20

Financial Efficiency

Return on equity (ROE) is -14.14% and return on invested capital (ROIC) is -26.26%.

Return on Equity (ROE)	-14.14%
Return on Assets (ROA)	-3.04%
Return on Invested Capital (ROIC)	-26.26%
Return on Capital Employed (ROCE)	-23.66%
Weighted Average Cost of Capital (WACC)	5.08%
Revenue Per Employee	18.67M
Profits Per Employee	-623,200
Employee Count	9
Asset Turnover	0.93
Inventory Turnover	1.92

Taxes

Income Tax	-579,980
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.02% in the last 52 weeks. The beta is 0.15, so Brawn Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+6.02%
50-Day Moving Average	21.27
200-Day Moving Average	19.35
Relative Strength Index (RSI)	52.18
Average Volume (20 Days)	736

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Brawn Biotech had revenue of INR 168.03 million and -5.61 million in losses. Loss per share was -2.02.

Revenue	168.03M
Gross Profit	21.11M
Operating Income	-8.77M
Pretax Income	-6.19M
Net Income	-5.61M
EBITDA	-7.53M
EBIT	-8.77M
Loss Per Share	-2.02

Balance Sheet

The company has 1.89 million in cash and n/a in debt, with a net cash position of 1.89 million or 0.63 per share.

Cash & Cash Equivalents	1.89M
Total Debt	n/a
Net Cash	1.89M
Net Cash Per Share	0.63
Equity (Book Value)	37.05M
Book Value Per Share	12.97
Working Capital	27.67M

Cash Flow

In the last 12 months, operating cash flow was 334,280 and capital expenditures -1.51 million, giving a free cash flow of -1.17 million.

Operating Cash Flow	334,280
Capital Expenditures	-1.51M
Free Cash Flow	-1.17M
FCF Per Share	-0.39

Margins

Gross margin is 12.56%, with operating and profit margins of -5.22% and -3.34%.

Gross Margin	12.56%
Operating Margin	-5.22%
Pretax Margin	-3.68%
Profit Margin	-3.34%
EBITDA Margin	-4.48%
EBIT Margin	-5.22%
FCF Margin	n/a

Dividends & Yields

Brawn Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	9.75%
Shareholder Yield	9.75%
Earnings Yield	-8.50%
FCF Yield	-1.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3